IE
NRC icon

Israel Englander’s NRC Health Common Stock NRC Stock Holding History

Israel Englander’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,259
Closed -$169K – 6314
2025
Q3 		$169K Sell
13,259
-40,551
-75% -$608K ﹤0.01% 5589
2025
Q2 		$904K Buy
53,810
+11,770
+28% +$159K ﹤0.01% 4484
2025
Q1 		$538K Sell
42,040
-39,921
-49% -$641K ﹤0.01% 4765
2024
Q4 		$1.45M Sell
81,961
-149,637
-65% -$2.84M ﹤0.01% 3894
2024
Q3 		$5.29M Buy
231,598
+16,740
+8% +$378K ﹤0.01% 2788
2024
Q2 		$4.93M Buy
214,858
+143,454
+201% +$4.42M ﹤0.01% 2741
2024
Q1 		$2.83M Buy
71,404
+18,969
+36% +$750K ﹤0.01% 3431
2023
Q4 		$2.07M Buy
+52,435
New +$2.19M ﹤0.01% 3573
2023
Q3 		– Sell
-16,615
Closed -$723K – 6413
2023
Q2 		$723K Buy
16,615
+4,085
+33% +$180K ﹤0.01% 4285
2023
Q1 		$545K Buy
+12,530
New +$553K ﹤0.01% 4547
2022
Q2 		– Sell
-39,375
Closed -$1.56M – 7328
2022
Q1 		$1.56M Buy
39,375
+21,246
+117% +$832K ﹤0.01% 4094
2021
Q4 		$753K Buy
18,129
+13,157
+265% +$572K ﹤0.01% 4677
2021
Q3 		$210K Buy
+4,972
New +$250K ﹤0.01% 6085
2021
Q1 		– Sell
-7,325
Closed -$313K – 6338
2020
Q4 		$313K Buy
+7,325
New +$376K ﹤0.01% 4515
2020
Q2 		– Sell
-5,189
Closed -$236K – 4455
2020
Q1 		$236K Sell
5,189
-38
-0.7% -$2.28K ﹤0.01% 3301
2019
Q4 		$345K Buy
+5,227
New +$320K ﹤0.01% 3588
2019
Q2 		– Sell
-26,544
Closed -$1.02M – 4341
2019
Q1 		$1.02M Buy
+26,544
New +$1.04M ﹤0.01% 2849
2017
Q3 		– Sell
-36,495
Closed -$982K – 3747
2017
Q2 		$982K Buy
+36,495
New +$892K ﹤0.01% 2453

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's NRC Position: Q4 2025 in Review

Israel Englander sold out of NRC Health Common Stock (NRC) in Q4 2025, closing a stake of 13,259 shares — an estimated $169K sold.

Israel Englander first reported a position in NRC in Q2 2017 and held it in 18 quarters. The position peaked at $5.29M in Q3 2024. 117 funds tracked by Wall St. Rank hold NRC as of Q4 2025.

  • Israel Englander reported no remaining NRC Health Common Stock position as of Q4 2025 after selling out during the quarter.
  • Israel Englander sold 13,259 NRC Health Common Stock shares in Q4 2025, an estimated $169K.
  • Israel Englander first reported a position in NRC Health Common Stock in Q2 2017 and held it in 18 quarters.
  • Israel Englander's NRC Health Common Stock position peaked at $5.29M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.